DFCM
BNGO icon

Dark Forest Capital Management’s Bionano Genomics BNGO Stock Holding History

Dark Forest Capital Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,362
Closed -$429K – 534
2023
Q3 		$429K Buy
2,362
+2,341
+11,148% +$613K 0.03% 767
2023
Q2 		$7.69K Buy
+21
New +$9.48K ﹤0.01% 1000
2022
Q1 		– Sell
-119
Closed -$213K – 1304
2021
Q4 		$213K Buy
+119
New +$318K 0.08% 219

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dark Forest Capital Management's BNGO Position: Q4 2023 in Review

Dark Forest Capital Management sold out of Bionano Genomics (BNGO) in Q4 2023, closing a stake of 2,362 shares — an estimated $429K sold.

Dark Forest Capital Management first reported a position in BNGO in Q4 2021 and held it in 3 quarters. The position peaked at $429K in Q3 2023. 62 funds tracked by Wall St. Rank hold BNGO as of Q4 2023.

  • Dark Forest Capital Management reported no remaining Bionano Genomics position as of Q4 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 2,362 Bionano Genomics shares in Q4 2023, an estimated $429K.
  • Dark Forest Capital Management first reported a position in Bionano Genomics in Q4 2021 and held it in 3 quarters.
  • Dark Forest Capital Management's Bionano Genomics position peaked at $429K in Q3 2023.
  • 62 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2023.

Based on Dark Forest Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.